1.
From the 27MAR14 ASX Announcement "Final Data Confirms Successful Phase I/IIa Clinical Trial for PAT-SM6", paragraph 6:
"These data compare favorably with another antibody (Elotuzumab)..."
1.1
What happened with Elotuzumab ($710M):
"Bristol-Myers Squibb is paying $30 million upfront in a licensing deal....And it will pay up to $680 million more if the Phase I cancer therapy hits all of its development and sales milestones."
http://www.fiercebiotech.com/story/bms-inks-710m-development-deal-pdl/2008-08-20
1.3
PAB's current market cap ~$30M.
- Forums
- ASX - By Stock
- PAB
- pab research summary #2
pab research summary #2
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.6¢ |
Change
-0.001(14.3%) |
Mkt cap ! $12.34M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.6¢ | $1.953K | 325.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4291214 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 500160 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 4291214 | 0.006 |
14 | 4949991 | 0.005 |
12 | 7264199 | 0.004 |
6 | 6065682 | 0.003 |
2 | 2770000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 500160 | 1 |
0.008 | 2092233 | 5 |
0.010 | 126000 | 2 |
0.011 | 680000 | 2 |
0.012 | 292407 | 2 |
Last trade - 11.14am 06/09/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |